The initial rate-limiting enzymes of glycolysis, hexokinase 1 (HK1) and hexokinase 2 (HK2), are markedly overexpressed in breast cancer, with the suppression of HK expression leading to the dampening of breast cancer cell proliferation, invasion, and migration (71). Here, HK2 is linked to breast cancer.